Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation

Bone Marrow Transplantation

Volumn 45, Issue 3, 2010, Pages 442-449

  Guerin V ^a   Dalle, J H ^a   Pedron B ^a   Ouachee Chardin M ^a   Yakouben, K ^a   Baruchel, A ^a   Sterkers, G ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Cytomegalovirus; Hematopoietic stem cell transplantationchildren; Immune recovery

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2;

ACUTE LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; GASTRITIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; VIREMIA; VIRUS LOAD;

ADOLESCENT; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; INFANT; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MALE; VIREMIA;

EID: 77949424031     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.179     Document Type: Article

References (24)

1. Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G et al., Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8T cells. J Exp Med 2005; 201: 1031-1036.
2. Gratama JW, van Esser JW, Lamers CH, Tournay C, Lowenberg B, Bolhuis RL et al., Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001; 98: 1358-1364.
3. Reusser P, Cathomas G, Attenhofer R, Tamm M, Thiel G. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J Infect Dis 1999; 180: 247-253.
4. Sacre K, Carcelain G, Cassoux N, Fillet AM, Costagliola D, Vittecoq D et al., Repertoire, diversity, and differentiation of specific CD8T cells are associated with immune protection against human cytomegalovirus disease. J Exp Med 2005; 201: 1999-2010.
5. Chen SF, Tu WW, Sharp MA, Tongson EC, He XS, Greenberg HB et al., Antiviral CD8T cells in the control of primary human cytomegalovirus infection in early childhood. J Infect Dis 2004; 189: 1619-1627.
6. Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003; 101: 2686-2692.
7. Hebart H, Daginik S, Stevanovic S, Grigoleit U, Dobler A, Baur M et al., Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon- gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood 2002; 99: 3830-3837.
8. Foster AE, Gottlieb DJ, Sartor M, Hertzberg MS, Bradstock KF. Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 501-511.
9. Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang ML, Myerson D et al., Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003; 101: 407-414.
10. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED et al., Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995; 333: 1038-1044.
11. Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005; 174: 1037-1045.
12. Boaz MJ, Waters A, Murad S, Easterbrook PJ, Vyakarnam A. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4T cell responses is associated with nonprogression in HIV-1 infection. J Immunol 2002; 169: 6376-6385.
13. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ et al., Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13: 843-850.
14. Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R et al., Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J Virol 2005; 79: 14169-14178.
15. Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, Routy JP et al., HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 2003; 198: 1909-1922.
16. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP et al., Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007; 178: 5217-5226.
17. Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P et al., Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood 2003; 102: 3060-3067.
18. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83: 1971-1979.
19. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097.
20. Sester M, Sester U, Gartner B, Heine G, Girndt M, Mueller-Lantzsch N et al., Levels of virus-specific CD4T cells correlate with cytomegalovirus control and predict virusinduced disease after renal transplantation. Transplantation 2001; 71: 1287-1294.
21. Zaunders JJ, Dyer WB, Munier ML, Ip S, Liu J, Amyes E et al., CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells. J Virol 2006; 80: 10151-10161.
22. Lilleri D, Gerna G, Fornara C, Lozza L, Maccario R, Locatelli F. Prospective simultaneous quantification of human cytomegalovirus- specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 2006; 108: 1406-1412.
23. Pourgheysari B, Piper KP, McLarnon A, Arrazi J, Bruton R, Clark F et al., Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT. Bone Marrow Transplant 2009; 43: 853-861.
24. Lilleri D, Fornara C, Revello MG, Gerna G. Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection. J Infect Dis 2008; 198: 536-543.